Usana Health Sciences Stock Today
| USNA Stock | USD 25.48 0.01 0.04% |
PerformanceVery Weak
| Odds Of DistressLow
|
USANA Health is trading at 25.48 as of the 6th of April 2025, a 0.04 percent increase since the beginning of the trading day. The stock's open price was 25.47. USANA Health has only a 6 % chance of going through financial distress over the next few years, but has generated negative returns over the last 90 days. The performance scores are derived for the period starting the 6th of January 2025 and ending today, the 6th of April 2025. Click here to learn more.
Business Domain Household & Personal Products | IPO Date 25th of July 1996 | Category Consumer Defensive | Classification Consumer Staples |
USANA Health Sciences, Inc. develops, manufactures, and sells science-based nutritional and personal care products. USANA Health Sciences, Inc. was founded in 1992 and is headquartered in Salt Lake City, Utah. Usana Health operates under Packaged Foods classification in the United States and is traded on New York Stock Exchange. The company has 18.9 M outstanding shares of which 847.06 K shares are at this time shorted by private and institutional investors with about 3.36 trading days to cover. More on USANA Health Sciences
Moving together with USANA Stock
Moving against USANA Stock
Follow Valuation Options Odds of Bankruptcy
Check how we calculate scores
USANA Stock Highlights
ESG Sustainability
Environmental | Governance | Social |
| Chairman | Kevin Guest | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Business Concentration | Personal Care Products, Household & Personal Products, Consumer Defensive, NYSE Composite, SP Small-Cap 600, Nasdaq Benchmark Consumer, Consumer Staples, Personal Care Products, Packaged Foods, Consumer Defensive (View all Sectors) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Average Analyst Recommendation | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Financial Strength
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt LevelsUSANA Health can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand USANA Health's financial leverage. It provides some insight into what part of USANA Health's total assets is financed by creditors.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
USANA Health Sciences (USNA) is traded on New York Stock Exchange in USA. It is located in 3838 West Parkway Boulevard, Salt Lake City, UT, United States, 84120 and employs 1,700 people. USANA Health is listed under Personal Care Products category by Fama And French industry classification. The company currently falls under 'Small-Cap' category with a current market capitalization of 481.69 M. USANA Health Sciences conducts business under Personal Care Products sector and is part of Consumer Staples industry. The entity has 18.9 M outstanding shares of which 847.06 K shares are at this time shorted by private and institutional investors with about 3.36 trading days to cover.
USANA Health Sciences currently holds about 246.88 M in cash with 60.99 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 12.82.
Check USANA Health Probability Of Bankruptcy
Ownership AllocationUSANA Health Sciences secures a total of 18.9 Million outstanding shares. Over half of USANA Health's outstanding shares are owned by institutions. These institutions are typically referred to as corporate investors that take positions in a given instrument to benefit from reduced trade commissions. Also note that nearly one hundred eleven thousand five hundred thirty-seven invesors are currently shorting USANA Health expressing very little confidence in its future performance.
Check USANA Ownership Details
USANA Stock Institutional Holders
| Instituion | Recorded On | Shares | |
| Charles Schwab Investment Management Inc | 2024-12-31 | 140.9 K | |
| Northern Trust Corp | 2024-12-31 | 135.9 K | |
| Citadel Advisors Llc | 2024-12-31 | 131.4 K | |
| Jacobs Levy Equity Management, Inc. | 2024-12-31 | 129 K | |
| Amvescap Plc. | 2024-12-31 | 116.4 K | |
| Assenagon Asset Management Sa | 2024-12-31 | 108.3 K | |
| Royal Bank Of Canada | 2024-12-31 | 101.5 K | |
| Goldman Sachs Group Inc | 2024-12-31 | 100.5 K | |
| Ubs Group Ag | 2024-12-31 | 85.4 K | |
| Blackrock Inc | 2024-12-31 | 1.8 M | |
| Vanguard Group Inc | 2024-12-31 | 1.5 M |
USANA Health Historical Income Statement
USANA Stock Against Markets
USANA Health Corporate Directors
| Andrew Masuda | Director Relations | Profile | |
| Peggie Pelosi | Independent Director | Profile | |
| Frederic Winssinger | Independent Director | Profile | |
| Feng Peng | Independent Director | Profile |
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in USANA Health Sciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. You can also try the ETFs module to find actively traded Exchange Traded Funds (ETF) from around the world.
Is Personal Care Products space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of USANA Health. If investors know USANA will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about USANA Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.74) | Earnings Share 2.19 | Revenue Per Share | Quarterly Revenue Growth (0.03) | Return On Assets |
The market value of USANA Health Sciences is measured differently than its book value, which is the value of USANA that is recorded on the company's balance sheet. Investors also form their own opinion of USANA Health's value that differs from its market value or its book value, called intrinsic value, which is USANA Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because USANA Health's market value can be influenced by many factors that don't directly affect USANA Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between USANA Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if USANA Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, USANA Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.